Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Hengrui Medicine: Class 1 innovative drug Haquepopa Ethanolamine Tablets added with new indications
Hengrui Medicine Announcement: Recently, the company received a notice from the National Medical Products Administration approving an additional indication for its self-developed Class 1 innovative drug, Haitupopa Ethanolamine Tablets. The relevant details are as follows:
Drug name: Haitupopa Ethanolamine Tablets
Dosage form: Tablets
Specifications: 2.5mg, 5mg
Approved indication: This product, in combination with immunosuppressants, is used to treat newly diagnosed severe aplastic anemia (SAA) patients aged 15 and above.